SEARCH

SEARCH BY CITATION

References

  • Arcese, W., Rocha, V., Labopin, M., Sanz, G., Iori, A.P., De Lima, M., Sirvent, A., Busca, A., Asano, S., Ionescu, I., Wernet, P. & Gluckman, E. (2006) Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica, 91, 223230.
  • Atsuta, Y., Suzuki, R., Nagamura-Inoue, T., Taniguchi, S., Takahashi, S., Kai, S., Sakamaki, H., Kouzai, Y., Kasai, M., Fukuda, T., Azuma, H., Takanashi, M., Okamoto, S., Tsuchida, M., Kawa, K., Morishima, Y., Kodera, Y. & Kato, S. (2009) Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood, 113, 16311638.
  • Ballen, K.K., Spitzer, T.R., Yeap, B.Y., McAfee, S., Dey, B.R., Attar, E., Haspel, R., Kao, G., Liney, D., Alyea, E., Lee, S., Cutler, C., Ho, V., Soiffer, R. & Antin, J.H. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biology of Blood and Marrow Transplantation, 13, 8289.
  • Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., Miller, J.S. & Wagner, J.E. (2003) Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood, 102, 19151919.
  • Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B., Mille, J.S., Verfaillie, C.M. & Wagner, J.E. (2005a) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105, 13431347.
  • Barker, J.N., Hough, R.E., Van Burik, J.A., DeFor, T.E., MacMillan, M.L., O’Brien, M.R. & Wagner, J.E. (2005b) Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biology of Blood and Marrow Transplantation, 11, 362370.
  • Barker, J.N., Scaradavou, A., Stevens, C. & Rubinstein, P. (2007) The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy. Blood, 110, a333.
  • Barker, J.N., Rocha, V. & Scaradavou, A. (2008) Optimizing unrelated donor cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 154161.
  • Brunstein, C.G., Weisdorf, D.J., DeFor, T., Barker, J.N., Tolar, J., Van Burik, J.A. & Wagner, J.E. (2006) Marked increased risk of Epstein–Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood, 108, 28742880.
  • Brunstein, C.G., Barker, J.N., Weisdorf, D.J., DeFor, T.E., Miller, J.S., Blazar, B.R., McGlave, P.B. & Wagner, J.E. (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood, 110, 30643070.
  • Brunstein, C., Weisdorf, D., DeFor, T., Miller, J.S., McGlave, P.B., Blazar, B.R. & Wagner, J.E. (2008) Favorable leukemia-free survival (LFS) for adults and children undergoing myeloablative umbilical cord blood (UCB) transplantation with cyclophosphamide (CY), fludarabine (FLU) and total body irradiation (TBI): a single center analysis of 194 patients. Blood, 112, a1957.
  • Brunstein, C.G., Cantero, S., Cao, Q., Majhail, N., McClune, B., Burns, L.J., Tomblyn, M., Miller, J.S., Blazar, B.R., McGlave, P.B., Weisdorf, D.J. & Wagner, J.E. (2009) Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 214222.
  • Carpenter, P.A., Snyder, D.S., Flowers, M.E., Sanders, J.E., Gooley, T.A., Martin, P.J., Appelbaum, F.R. & Radich, J.P. (2007) Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. Blood, 109, 27912793.
  • Casper, J., Knauf, W., Kiefer, T., Wolff, D., Steiner, B., Hammer, U., Wegener, R., Kleine, H.D., Wilhelm, S., Knopp, A., Hartung, G., Dölken, G. & Freund, M. (2004) Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood, 103, 725731.
  • Ciurea, S.O. & Andersson, B.S. (2009) Busulfan in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 15, 523536.
  • Cornetta, K., Laughlin, M., Carter, S., Wall, D., Weinthal, J., Delaney, C., Wagner, J., Sweetman, R., McCarthy, P. & Chao, N. (2005) Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). Biology of Blood and Marrow Transplantation, 11, 149160.
  • Eapen, M., Rubinstein, P., Zhang, M.J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F.R., Champlin, R.E., Klein, J.P., Horowitz, M.M. & Wagner, J.E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369, 19471954.
  • Eldjerou, L.K., Chaudhury, S., He, M., Arcila, M.E., Salazar, P.A., O’Reilly, R.J., Barker, J.N. & Moore, M.A.S. (2008) Graft-vs-graft immune interaction is the likely mechanism of absolute unit dominance in double unit cord blood (DCB) transplantation using patient DCB grafts: an in vivo but not in vitro phenomenon. Blood, 112, a3486.
  • Gluckman, E. & Rocha, V. (2004) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord–Cord Blood Transplant Group. Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis. Blood Cells, Molecules, and Diseases, 33, 271273.
  • Gutman, J.A., Leisenring, W., Appelbaum, F.R., Woolfrey, A.E. & Delaney, C. (2008) Decreased relapse rates without excessive transplant related mortality following cord blood transplantation (CBT): a matched cohort analysis comparing myeloablative cord, matched unrelated, and mismatched unrelated donor transplants. Blood, 112, a968.
  • Gutman, J.A., Turtle, C., Manley, T.J., Riddell, S.R. & Delaney, C. (2009) Engraftment of a Single Unit Following Double Unit Umbilical Cord Hematopoietic Cell Transplantation Coincides with a CD8+ T Cell Response to the Non-Engrafted Unit. ISCT Annual Meeting. Oral presentation.
  • Hamza, N.S., Lisgaris, M., Yadavalli, G., Nadeau, L., Fox, R., Fu, P., Lazarus, H.M., Koc, O.N., Salata, R.A. & Laughlin, M.J. (2004) Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. British Journal of Haematology, 124, 488498.
  • Holowiecki, J., Giebel, S., Beelen, D., Trenschel, R., Wandt, H., Schaefer-Eckart, K., Ruutu, T., Volin, L., Einsele, H., Stuhler, G., Uharek, L., Blau, I., Bornhaeuser, M., Zander, A., Kroeger, N., Aschan, J., Wojnar, J., Markiewicz, M., Freund, M. & Casper, J. (2007) Phase II multicenter trial to evaluate the safety and efficacy of low-toxicity treosulfan/fludarabine conditioning prior to allogeneic haematopoietic stem cell transplantation in patients with acute myeloid leukemia. Blood, 110, a621.
  • Horwitz, M.E., Morris, A., Gasparetto, C., Sullivan, K., Long, G., Chute, J., Rizzieri, D., McPherson, J. & Chao, N. (2008) Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. Biology of Blood and Marrow Transplantation, 14, 591594.
  • Kögler, G., Enczmann, J., Rocha, V., Gluckman, E. & Wernet, P. (2005) High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplantation, 36, 10331041.
  • Konuma, T., Takahashi, S., Ooi, J., Tomonari, A., Tsukada, N., Kato, S., Sato, A., Monma, F., Kasahara, S., Nagamura-Inoue, T., Uchimaru, K., Iseki, T., Tojo, A., Yamaguchi, T. & Asano, S. (2009) Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age. Annals of Hematology, 88, 581588.
  • Kurtzberg, J., Prasad, V.K., Carter, S.L., Wagner, J.E., Baxter-Lowe, L.A., Wall, D., Kapoor, N., Guinan, E.C., Feig, S.A., Wagner, E.L. & Kernan, N.A. (2008) Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112, 43184327.
  • Laughlin, M.J., Eapen, M., Rubinstein, P., Wagner, J.E., Zhang, M.J., Champlin, R.E., Stevens, C., Barker, J.N., Gale, R.P., Lazarus, H.M., Marks, D.I., Van Rood, J.J., Scaradavou, A. & Horowitz, M.M. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. The New England Journal of Medicine, 351, 22652275.
  • Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., Messina, C., Ortega, J., Badell-Serra, I., Plouvier, E., Souillet, G., Jouet, J.P., Pasquini, R., Ferreira, E., Garnier, F. & Gluckman, E. (1999) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord–Cord Blood Transplant Group. Blood, 93, 36623671.
  • MacMillan, M.L., Weisdorf, D.J., Brunstein, C.G., Cao, Q., DeFor, T.E., Verneris, M.R., Blazar, B.R. & Wagner, J.E. (2009) Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood, 113, 24102415.
  • Majhail, N.S., Weisdorf, D.J., Wagner, J.E., Defor, T.E., Brunstein, C.G. & Burns, L.J. (2006a) Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood, 107, 38043807.
  • Majhail, N.S., Brunstein, C.G. & Wagner, J.E. (2006b) Double umbilical cord blood transplantation. Current Opinion in Immunology, 18, 571575.
  • Majhail, N.S., Brunstein, C.G., Tomblyn, M., Thomas, A.J., Miller, J.S., Arora, M., Kaufman, D.S., Burns, L.J., Slungaard, A., McGlave, P.B., Wagner, J.E. & Weisdorf, D.J. (2008) Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of Blood and Marrow Transplantation, 14, 282289.
  • Matà, S., Guidi, S., Nozzoli, C., Orsi, A., Pratesi, A., Mascalchi, M., Moretti, M., Letizia, L., Rombolà, G., Sorbi, S. & Bosi, A. (2008) Human herpesvirus 6-associated limbic encephalitis in adult recipients of unrelated umbilical cord blood transplantation. Bone Marrow Transplantation, 42, 693695.
  • Matsumura, T., Narimatsu, H., Kami, M., Yuji, K., Kusumi, E., Hori, A., Murashige, N., Tanaka, Y., Masuoka, K., Wake, A., Miyakoshi, S., Kanda, Y. & Taniguchi, S. (2007) Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biology of Blood and Marrow Transplantation, 13, 577583.
  • McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., Torok-Storb, B., Yu, C., Blume, K.G. & Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 33903400.
  • Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K.W., Filipovich, A., Takahashi, T.A., Vowels, M., Ortega, J., Bordigoni, P., Shaw, P.J., Yaniv, I., Machado, A., Pimentel, P., Fagioli, F., Verdeguer, A., Jouet, J.P., Diez, B., Ferreira, E., Pasquini, R., Rosenthal, J., Sievers, E., Messina, C., Iori, A.P., Garnier, F., Ionescu, I., Locatelli, F. & Gluckman, E. (2003) Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood, 102, 42904297.
  • Miyakoshi, S., Yuji, K., Kami, M., Kusumi, E., Kishi, Y., Kobayashi, K., Murashige, N., Hamaki, T., Kim, S.W., Ueyama, J., Mori, S., Morinaga, S., Muto, Y., Masuo, S., Kanemaru, M., Hayashi, T., Takaue, Y. & Taniguchi, S. (2004) Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clinical Cancer Research, 10, 35863592.
  • Miyakoshi, S., Kusumi, E., Matsumura, T., Hori, A., Murashige, N., Hamaki, T., Yuji, K., Uchida, N., Masuoka, K., Wake, A., Kanda, Y., Kami, M., Tanaka, Y. & Taniguchi, S. (2007) Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. Biology of Blood and Marrow Transplantation, 13, 771777.
  • Montesinos, P., Sanz, J., Cantero, S., Lorenzo, I., Martın, G., Saavedra, S., Palau, J., Romero, M., Montava, A., Senent, L., Martınez, J., Jarque, I., Salavert, M., Cordoba, J., Gomez, L., Weiss, S., Moscard, F., De La Rubia, J., Larrea, L., Sanz, M.A. & Sanz, G.F. (2009) Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 730740.
  • Muramatsu, H., Watanabe, N., Matsumoto, K., Ito, M., Yoshikawa, T., Kato, K. & Kojima, S. (2009) Primary infection of human herpesvirus-6 in an infant who received cord blood SCT. Bone Marrow Transplantation, 43, 8384.
  • Narimatsu, H., Matsumura, T., Kami, M., Miyakoshi, S., Kusumi, E., Takagi, S., Miura, Y., Kato, D., Inokuchi, C., Myojo, T., Kishi, Y., Murashige, N., Yuji, K., Masuoka, K., Yoneyama, A., Wake, A., Morinaga, S., Kanda, Y. & Taniguchi, S. (2005) Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biology of Blood and Marrow Transplantation, 11, 429436.
  • Narimatsu, H., Kami, M., Kato, D., Matsumura, T., Murashige, N., Kusumi, E., Yuji, K., Hori, A., Shibata, T., Masuoka, K., Wake, A., Miyakoshi, S., Morinaga, S. & Taniguchi, S. (2007) Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease, 9, 1115.
  • Narimatsu, H., Watanabe, M., Kohno, A., Sugimoto, K., Kuwatsuka, Y., Uchida, T., Murata, M., Miyamura, K. & Morishita, Y. (2008) High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. Bone Marrow Transplantation, 41, 753756.
  • Nemecek, E.R., Sorror, M.L., Doney, K.C., Scott, B.S., Kovacsovics, T.J., Maziarz, R.T., Woolfrey, A.E., Sanders, J., O’Donnell, P.V., Guthrie, K. & Deeg, H.J. (2008) A regimen of treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation (HCT) for high-risk hematologic malignancies is associated with low treatment-related mortality. Blood, 112, a2994.
  • Okada, M., Fujimori, Y., Misawa, M., Kai, S., Nakajima, T., Okikawa, Y., Satake, A., Itoi, H., Takatsuka, H., Itsukuma, T., Nishioka, K., Tamaki, H., Ikegame, K., Hara, H. & Ogawa, H. (2008) Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biology of Blood and Marrow Transplantation, 14, 896903.
  • Ooi, J., Takahashi, S., Tomonari, A., Tsukada, N., Konuma, T., Kato, S., Kasahara, S., Sato, A., Monma, F., Nagamura, F., Iseki, T., Tojo, A. & Asano, S. (2008) Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia. Biology of Blood and Marrow Transplantation, 14, 13411347.
  • Ooi, J., Takahashi, S., Tomonari, A., Tsukada, N., Konuma, T., Kato, S., Kasahara, S., Sato, A., Monma, F., Nagamura, F., Iseki, T., Tojo, A. & Asano, S. (2009) Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL. Bone Marrow Transplantation, 43, 455459.
  • Parody, R., Martino, R., Rovira, M., Vazquez, L., Vázquez, M.J., De La Cámara, R., Blazquez, C., Fernández-Avilés, F., Carreras, E., Salavert, M., Jarque, I., Martín, C., Martínez, F., López, J., Torres, A., Sierra, J. & Sanz, G.F. (2006) Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biology of Blood and Marrow Transplantation, 12, 734748.
  • Peters, W.P., Henner, W.D., Grochow, L.B., Olsen, G., Edwards, S., Stanbuck, H., Stuart, A., Gockerman, J., Moore, J., Bast, Jr, R.C., Seigler, H.F. & Colvin, O.M. (1987) Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. Cancer Research, 47, 64026406.
  • Rocha, V., Wagner, J.E., Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. & Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. The New England Journal of Medicine, 342, 18461854.
  • Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S. & Gluckman, E. (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood, 97, 29622971.
  • Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., De Lima, M., Finke, J., Frassoni, F. & Gluckman, E. (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. The New England Journal of Medicine, 351, 22762285.
  • Rodrigues, C.A., Sanz, G., Brunstein, C.G., Sanz, J., Wagner, J.E., Renaud, M., De Lima, M., Cairo, M.S., Fürst, S., Rio, B., Dalley, C., Carreras, E., Harousseau, J.L., Mohty, M., Taveira, D., Dreger, P., Sureda, A., Gluckman, E. & Rocha, V. (2009) Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. Journal of Clinical Oncology, 27, 256263.
  • Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H.G., Burns, W.H., Elfenbein, G.J., Kaizer, H., Mellits, D., Sensenbrenner, L.L., Stuart, R.K. & Yeager, A.M. (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. The New England Journal of Medicine, 309, 13471353.
  • Sanz, J., Arcese, W., Hernandez-Boluda, J.C., Ferra, C., Gonzalez, M., Martin, C., Serrano, D., Cordoba, R., Picardi, A., Solano, C., Sanz, M.A. & Sanz, G. (2007) Low transplant-related mortality in patients with hematologic malignancies undergoing umbilical cord blood transplantation (UCBT) with thiotepa (TT), once-daily intravenous (IV) busulfan (BU), fludarabine (FLU) and anti-thymocyte globulin (ATG). Blood, 110, a618.
  • Shereck, E.B., Cooney, E., Van De Ven, C., Della-Lotta, P. & Cairo, M.S. (2007) A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatric Blood & Cancer, 49, 306312.
  • Takahashi, S., Ooi, J., Tomonari, A., Konuma, T., Tsukada, N., Oiwa-Monna, M., Fukuno, K., Uchiyama, M., Takasugi, K., Iseki, T., Tojo, A., Yamaguchi, T. & Asano, S. (2007) Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood, 109, 13221330.
  • Takami, A., Mochizuki, K., Asakura, H., Yamazaki, H., Okumura, H. & Nakao, S. (2005) High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematologica, 90, 12901292.
  • Tanaka, M., Taguchi, J., Hyo, R., Kawano, T., Hashimoto, C., Motomura, S., Kodama, F., Kobayashi, S., Okabe, G., Maruta, A., Nagao, T. & Ishigatsubo, Y. (2005) Human herpesvirus-6 encephalitis after unrelated cord blood transplantation. Leukaemia & Lymphoma, 46, 561566.
  • Tomonari, A., Takahashi, S., Ooi, J., Iseki, T., Takasugi, K., Uchiyama, M., Konuma, T., Futami, M., Ohno, N., Uchimaru, K., Tojo, A. & Asano, S. (2005) Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation. International Journal of Hematology, 81, 352355.
  • Tomonari, A., Takahashi, S., Ooi, J., Nakaoka, T., Takasugi, K., Uchiyama, M., Tsukada, N., Konuma, T., Iseki, T., Tojo, A. & Asano, S. (2006) Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. European Journal of Haematology, 77, 4650.
  • Tomonari, A., Takahashi, S., Ooi, J., Tsukada, N., Konuma, T., Kato, S., Kasahara, S., Iseki, T., Yamaguchi, T., Tojo, A. & Asano, S. (2008a) Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan. European Journal of Haematology, 80, 251257.
  • Tomonari, A., Takahashi, S., Ooi, J., Tsukada, N., Konuma, T., Kobayashi, T., Takasugi, K., Iseki, T., Tojo, A. & Asano, S. (2008b) Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplantation, 41, 371376.
  • Tutschka, P.J., Copelan, E.A. & Klein, J.P. (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood, 70, 13821388.
  • Vandenbosch, K., Ovetchkine, P., Champagne, M.A., Haddad, E., Alexandrov, L. & Duval, M. (2008) Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biology of Blood and Marrow Transplantation, 14, 867871.
  • Verneris, M.V., Brunstein, C., DeFor, T.E., Barker, J., Weisdorf, D.J., Blazar, B.R., Miller, J.S. & Wagner, J.E. (2005) Risk of relapse (REL) after umbilical cord blood transplantation (UCBT) in patients with acute leukemia: marked reduction in recipients of two units. Blood, 106, 305.
  • Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. & Davies, S.M. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 16111618.
  • Walker, C.M., Van Burik, J.A., De For, T.E. & Weisdorf, D.J. (2007) Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biology of Blood and Marrow Transplantation, 13, 11061115.
  • Wall, D.A., Carter, S.L., Kernan, N.A., Kapoor, N., Kamani, N.R., Brochstein, J.A., Frangoul, H., Goyal, R.K., Horan, J.T., Pietryga, D., Wagner, J.E. & Kurtzberg, J. (2005) Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biology of Blood and Marrow Transplantation, 11, 637646.
  • Waller, A.F., Wang, F. & Waller, N. (2007) A mathematical model of stochastic engraftment by non-interacting single umbilical cord blood (UCB) grafts predicts accelerated engraftment using multiple UCB grafts. Blood, 110, a2034.
  • Yamada, M.F., Miyamura, K., Fujiwara, T., Kohata, K., Okitsu, Y., Ohguchi, H., Yamamoto, J., Yokoyama, H., Tomiya, Y., Ishizawa, K., Kameoka, J. & Harigae, H. (2008) Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis. Transplantation Proceedings, 40, 36373642.
  • Yazaki, M., Atsuta, Y., Kato, K., Kato, S., Taniguchi, S., Takahashi, S., Ogawa, H., Kouzai, Y., Kobayashi, T., Inoue, M., Kobayashi, R., Nagamura-Inoue, T., Azuma, H., Takanashi, M., Kai, S., Nakabayashi, M. & Saito, H. (2009) Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 439446.